Showing results (671-680 of 778) with videos related to

Sort By:
Pageof 78
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 11, 2019
An Ex Vivo Test of Complement Activation on Endothelium for Individualized Eculizumab Therapy in Hemolytic Uremic SyndromeMiriam Galbusera, Marina Noris, Sara Gastoldi, et al.
JCI Insight|August 10, 2023
A phase I study of autologous mesenchymal stromal cells for severe steroid-dependent nephrotic syndromeMarina Vivarelli, Manuela Colucci, Mattia Algeri, et al.
Blood|April 20, 2006
Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcomeJessica Caprioli, Marina Noris, Simona Brioschi, et al.
American Journal of Nephrology|November 3, 2025
Endothelin-1 and Cardio-Kidney Events among Patients with Chronic Kidney Disease, Diabetes, and AnemiaFinnian R Mc Causland, Brian L Claggett, Petr Jarolim, et al.
Diabetes|September 17, 2016
Renal and Systemic Effects of Calorie Restriction in Patients With Type 2 Diabetes With Abdominal Obesity: A Randomized Controlled TrialPiero Ruggenenti, Manuela Abbate, Barbara Ruggiero, et al.
Transplantation|November 4, 2015
Prevention of Transnational Transplant-Related Crimes-What More Can be Done?Dominique E Martin, Kristof Van Assche, Beatriz Domínguez-Gil, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 31, 2010
Effects of add-on fluvastatin therapy in patients with chronic proteinuric nephropathy on dual renin-angiotensin system blockade: the ESPLANADE trialPiero Ruggenenti, Annalisa Perna, Marcello Tonelli, et al.
Kidney International|March 4, 2011
A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosisHoward Trachtman, Fernando C Fervenza, Debbie S Gipson, et al.
The Journal of Cell Biology|July 18, 2020
EGF receptor-mediated FUS phosphorylation promotes its nuclear translocation and fibrotic signalingManuel Chiusa, Wen Hu, Jozef Zienkiewicz, et al.
Journal of the American Society of Nephrology : JASN|April 12, 2014
The endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathyDick de Zeeuw, Blai Coll, Dennis Andress, et al.
Pageof 78